MYDGF and metabolic dysfunction-associated steatotic liver disease: To the best of our knowledge, this is the first time that myeloid cell-derived MYDGF has been found to protect against NAFLD, and that the bone marrow, which functions as an endocrine organ, has been shown to regulate liver fat metabolism via MYDGF.